Skip to main content
Log in

Antikoagulation und Antiarrhythmika nach Vorhofflimmerablation

Anticoagulation and antiarrhythmic drug therapy after catheter ablation of atrial fibrillation

  • Published:
Clinical Research in Cardiology Supplements Aims and scope

Zusammenfassung

Prospektive Untersuchungen zur Gabe von Antikoagulanzien und Antiarrhythmika nach Vorhofflimmerablation liegen bislang nicht vor. Allerdings existieren Expertenempfehlungen aus dem Jahre 2007, die zu Indikation und Dauer einer Antikoagulation sowie zum Einsatz von Antiarrhythmika nach der Ablationsprozedur Stellung nehmen. Eine orale Antikoagulation wird für alle Patienten postinterventionell für mindestens 2 Monate empfohlen. Bei Patienten mit einem CHADS2-Score ≥2 sollte die Antikoagulation generell nicht beendet werden, unabhängig vom Vorhandensein oder Typ des Vorhofflimmerns. Antiarrhythmika können in den ersten 3 Monaten nach Ablation Vorhofflimmerrezidive unterdrücken, die in erster Linie auf postablatorischen inflammatorischen Prozessen beruhen. Auch nach Absetzen der Antiarrhythmika auftretende Arrhythmierezidive lassen sich medikamentös antiarrhythmisch behandeln, da primär wirkungslose Antiarrhythmika nach dem Ablationsversuch durchaus effektiv sein können.

Abstract

There are still no prospective studies concerning the use of anticoagulants and antiarrhythmic drugs after catheter ablation of atrial fibrillation. However, since 2007 experts have been stating recommendations for the indication and duration of anticoagulation as well as for the use of antiarrhythmic drugs after the ablation procedure. Postinterventionally oral anticoagulation is recommended for all patients for at least 2 months. Anticoagulation should continue in all patients who have a CHADS2 score ≥2, the type or persistence of atrial fibrillation then is not important. For the first 3 months antiarrhythmic drugs can successfully suppress relapses of atrial fibrillation which are caused by post-interventional tissue inflammation. In case of a relapse of atrial fibrillation antiarrhythmic drugs, which were initially ineffective, could be used successfully after the catheter ablation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Bertaglia E, Stabile G, Senatore G, Zoppo F, Turco P, Amellone C, De SA, Fazzari M, Pascotto P (2005) Predictive value of early atrial tachyarrhythmias recurrence after circumferential anatomical pulmonary vein ablation. Pacing Clin Electrophysiol 28:366–371

    Article  PubMed  Google Scholar 

  2. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJG, Damiano RJ, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ (2007) HRA/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Heart Rhythm 4:816–861

    Article  PubMed  Google Scholar 

  3. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Packer D, Skanes A (2005) Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111:1100–1105

    Article  PubMed  Google Scholar 

  4. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary. Eur Heart J 27:1979–2030

    Article  PubMed  Google Scholar 

  5. Gage BF, Waterman AD, Shannon W et al (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870

    Article  PubMed  CAS  Google Scholar 

  6. Haissaguerre M, Jais P, Shah DC, Garrigue S, Takahashi A, Lavergne T, Hocini M, Peng JT, Roudaut R, Clementy J (2000) Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 101:1409–1417

    PubMed  CAS  Google Scholar 

  7. Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li JH, Carbucicchio C, Kottkamp H (2005) Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 112:307–313

    Article  PubMed  Google Scholar 

  8. Hocini M, Sanders P, Jais P, Hsu LF, Takahashi Y, Rotter M, Clementy J, Haissaguerre M (2004) Techniques for curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol 15:1467–1471

    Article  PubMed  Google Scholar 

  9. Karch MR, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G, Dong J, Lamprecht K, Barthel P, Luciani E, Schömig A, Schmitt C (2005) Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: A randomized comparison between 2 current ablation strategies. Circulation 111:2875–2880

    Article  PubMed  Google Scholar 

  10. Kirchhof P, Breithardt G (2007) Therapie von Vorhofflimmern. Internist 48:819–831

    Article  PubMed  CAS  Google Scholar 

  11. Kuck KH, Ernst S, Dorwarth U, Hoffmann E, Pitschner H, Tebbenjohanns J, Kottkamp H (2007) Leitlinien zur Katheterablation. Clin Res Cardiol 96:833–849

    Article  PubMed  Google Scholar 

  12. Lee SH, Tai CT, Hsieh MH, Tsai CF, Lin YK, Tsao HM, Yu WC, Huang JL, Ueng KC, Cheng JJ et al (2004) Predictors of early and late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. J Interv Card Electrophysiol 10:221–226

    Article  PubMed  Google Scholar 

  13. Lemola K, Desjardins B, Sneider M, Case I, Cugh A, Good E, Han J, Tamirisa K, Tsemo A, Reich S, Tschopp D, Igic P, Elmouchi D, Bogun F, Pelosi F, Kazerooni E, Morady F, Oral H (2005) Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. Heart Rhythm 2:923–928

    Article  PubMed  Google Scholar 

  14. Mewis C, Neuberger HR, Böhm M (2006) Vorhofflimmern. Dtsch Med Wochenschr 131:2843–2854

    Article  PubMed  CAS  Google Scholar 

  15. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T (2004) A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 43:2044–2053

    Article  PubMed  Google Scholar 

  16. Oral H, Chugh A, Özaydin M, Good E, Fortino J, Sankaran S, Reich S, Igic P, Elmouchi D, Tschopp D, Wimmer A, Dey S, Crawford T, Pelosi F, Jongnarangsin K, Bogun F, Morady F (2006) Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 114:759–765

    Article  PubMed  Google Scholar 

  17. Oral H, Knight BP, Özaydin M, Tada H, Chugh A, Hassan S, Scharf C, Lai SW, Greenstein R, Pelosi F et al (2002) Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol 40:100–104

    Article  PubMed  Google Scholar 

  18. Ouyang F, Antz M, Ernst S, Hachiya H, Mavrakis H, Deger FT, Schaumann A, Chun J, Falk P, Hennig D et al (2005) Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation 111:127–135

    Article  PubMed  Google Scholar 

  19. Pappone C, Santinelli V (2004) The who, what, why, and how-to guide for circumferential pulmonary vein ablation. J Cardiovasc Electrophysiol 15:1226–1230

    Article  PubMed  Google Scholar 

  20. Schauerte P, Scherlag BJ, Pitha J, Scherlag MA, Reynolds D, Lazzara R, Jackman WM (2000) Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation 102:2774–2780

    PubMed  CAS  Google Scholar 

  21. Senatore G, Stabile G, Bertaglia E, Donnici G, De Simone A, Zoppo F, Turco P, Pascotto P, Fazzari M (2005) Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J Am Coll Cardiol 45:873–876

    Article  PubMed  Google Scholar 

  22. van Walraven WC, Hart RG, Wells GA et al (2003) A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 163:936–943

    Article  PubMed  Google Scholar 

  23. Verma A, Marrouche NF, Natale A (2004) Pulmonary vein antrum isolation: Intracardiac echocardiographyguided technique. J Cardiovasc Electrophysiol 15:1335–1340

    Article  PubMed  Google Scholar 

  24. Wyse DG (2007) Anticoagulation in atrial fibrillation: A contemporary viewpoint. Heart Rhythm 4:S35–S39

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Volkmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Volkmann, H., Bergmann, C. & Walter, M. Antikoagulation und Antiarrhythmika nach Vorhofflimmerablation. Clin Res Cardiol Suppl 3, 118–123 (2008). https://doi.org/10.1007/s11789-008-0035-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11789-008-0035-y

Schlüsselwörter

Key words

Navigation